JP1696682S - - Google Patents

Info

Publication number
JP1696682S
JP1696682S JPD2020-27401F JP2020027401F JP1696682S JP 1696682 S JP1696682 S JP 1696682S JP 2020027401 F JP2020027401 F JP 2020027401F JP 1696682 S JP1696682 S JP 1696682S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-27401F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-27401F priority Critical patent/JP1696682S/ja
Priority to US29/794,979 priority patent/USD989532S1/en
Application granted granted Critical
Publication of JP1696682S publication Critical patent/JP1696682S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-27401F 2020-12-18 2020-12-18 Active JP1696682S (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JPD2020-27401F JP1696682S (enExample) 2020-12-18 2020-12-18
US29/794,979 USD989532S1 (en) 2020-12-18 2021-06-16 Chair

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-27401F JP1696682S (enExample) 2020-12-18 2020-12-18

Publications (1)

Publication Number Publication Date
JP1696682S true JP1696682S (enExample) 2021-10-11

Family

ID=78001011

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-27401F Active JP1696682S (enExample) 2020-12-18 2020-12-18

Country Status (2)

Country Link
US (1) USD989532S1 (enExample)
JP (1) JP1696682S (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1022507S1 (en) * 2023-02-27 2024-04-16 Gubi A/S Chair
USD1068305S1 (en) * 2023-05-11 2025-04-01 Matthew Jordan Sonnenfeld Chair
USD1006469S1 (en) 2023-07-05 2023-12-05 Peijie ZHAO Chair

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD255293S (en) * 1977-07-15 1980-06-10 Giroflex Entwicklungs Ag Chair or similar article
USD527556S1 (en) * 2005-04-12 2006-09-05 Toshiyuki Kita Chair body
USD646496S1 (en) * 2010-10-18 2011-10-11 B&B Italia S.P.A. Armchair
USD678690S1 (en) * 2012-08-22 2013-03-26 Varier Furniture As Chair
USD720146S1 (en) * 2013-01-14 2014-12-30 B&B Italia S.P.A. Armchair
USD702451S1 (en) * 2013-01-28 2014-04-15 Fritz Hansen A/S Chair
USD771401S1 (en) * 2015-04-10 2016-11-15 B&B Italia S.P.A. Chair
JP1619966S (enExample) * 2017-10-02 2018-12-10
USD899799S1 (en) * 2019-05-27 2020-10-27 39F Usa Inc Chair
USD925243S1 (en) * 2020-03-08 2021-07-20 39F Usa Inc Chair

Also Published As

Publication number Publication date
USD989532S1 (en) 2023-06-20

Similar Documents

Publication Publication Date Title
JP1696682S (enExample)
CH719021A4 (enExample)
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos
AR134176A1 (es) VARIANTES DEL DOMINIO Fc CON UNIÓN MEJORADA AL RECEPTOR Fc